2nd Quarter - Termination

K&L GATES, LLP for ABRAXIS BIOSCIENCE, INC.

Firm
Client
Income
$90,000
Expenses
—
Terminated
Jul 1, 2010

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Health Care Act: issues related to the regulation of biologics.

LobbyistCovered position, as disclosed
STEPHEN COOPER —
BRUCE HEIMAN —
GEORGE KOCH New —
NICHOLAS LEIBHAM —
DENNIS POTTER —
BRITT JULIA SANDLER —
W DENNIS STEPHENS New CoS, Rep Stockman; LD, Rep Wicker
STEVEN RICHARDS VALENTINE —
JAMES T WALSH New U.S. Congressman

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th), H.R. 3962 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.